Register Now: Does Your Pharmaceutical WMS Grow with You?
News|Articles|February 20, 2025

Pharma Pulse 2/20/25: Global Launch Strategies in the Current Political Climate, Pharmacists Help Navigate Vaccine Schedules & more

The latest news for pharma industry insiders.

Global Launch Strategies in the Current Political Climate

James Foster, CEO and co-founder of Virax Biolabs, discusses how global launches are being impacted by changing geopolitical conditions.

Pharmacists Help Patients Navigate Vaccine Schedules

Many patients may struggle to understand the complex immunization schedules compiled by the CDC.

How AI Can Protect Vital Pipelines and Cables Deep in the Ocean

Militaries and startups use artificial intelligence to sift through vast amounts of data and power autonomous underwater vehicles, boosting efforts to surveil the seabed.

Rap Icon Nelly Joins the Kinexions 2025 Lineup

Kinaxis® announced that Nelly will be headlining the entertainment stage at Kinexions 2025, its annual supply chain community conference taking place in Austin, Texas from March 31 to April 2.

Virax Biolabs on LinkedIn

CEO James Foster shares insights on navigating global launch strategies amid political uncertainty. From adapting to tariffs to leveraging AI tools like ChatGPT for research, we’re staying nimble and ahead of the game.

Check out the interview with Pharmaceutical Executive. here: https://lnkd.in/eYT9Yt6N

#vrax #Biotech #Innovation #Leadership #GlobalStrategy #AI

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.